Last updated: 2026-09-08 22:18:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
ENvue Medical, Inc. (FEED) operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector and is listed on NASDAQ. The stock is currently priced at $4.25, with a market capitalization of $3.72M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.48 to $73.08. This page covers its latest market performance, valuation, price trends and company information.
$3.72M | |
$4.04 | |
$2,557.19 | |
$3.48 | |
$4.03 | |
168.41K | |
96.16K | |
-- | |
$73.08 | |
$3.48 | |
-- | |
-- |
ENvue Medical, Inc. (FEED) is trading at $3.80 in after-hours trading as of 2026-09-08 22:17:00, down 5.66% ($0.23) from the regular-session close of $4.03.
After-hours trading shows how investors are pricing FEED after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, ENvue Medical, Inc. (FEED) moved from $4.41 to $4.25, representing a decline of 3.73% ($0.16).
The stock traded between $3.77 and $4.76 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 39.72 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 1.1%
FEED is currently trading at $4.25, placing it 1.1% of the way from its 52-week low of $3.48 to its 52-week high of $73.08. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
ENvue Medical Inc is a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings. It focuses on two technology platforms: the ENvue Navigation Platform, which provides an electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract; FDA 510(k) cleared for adult use, it provides real-time bedside visualization of tube movement and supports informed decision-making during the placement procedure. Its Medical advances non-invasive therapy and minimally invasive navigation, with a commitment to patient safety, clinical usability, and technology innovation in healthcare environments, and the company's acoustic-based therapeutic technologies.
| Industry | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Employees | 14 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of ENvue Medical, Inc. (FEED) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.